category

Earnings Report

Nasdaq jumps 1%, Johnson & Johnson keeps Dow down

U.S. equity markets ended mixed after the U.S. Food and Drug Administration recommended Johnson & Johnson’s COVID-19 vaccine be paused amid blood-clotting concerns and consumer prices rose at the fastest pace in over eight years.

Nasdaq jumps 1.5%, S&P flirts with record

The Nasdaq and S&P 500 rallied Wednesday as details of President Biden’s $2 trillion infrastructure package were released on the final day of the first quarter.

Lululemon bolsters revenue, profit

Lululemon Athletica Inc. posted further gains in sales and profit to close out its latest fiscal year, showcasing the apparel company's continued resilience during a time when surging coronavirus cases shifted more consumer spending online.